top of page
< Back

Canagliflozin

坎格列淨

Mechanism of action:

Canagliflozin 是一種鈉-葡萄糖共轉運蛋白 2 抑制劑(SGLT2 inhibitor)。在正常情況下,腎臟會將過濾出的葡萄糖幾乎全部重新吸收,約 90% 的這些葡萄糖會經由近曲小管上皮細胞的 SGLT2 吸收,剩餘 10% 由 SGLT1 吸收。Canagliflozin 可抑制 SGLT2 的功能,阻止葡萄糖重新吸收,使大部分葡萄糖隨尿液排出。

​Reference(s):

1. Lamos EM et al. (2013). Canagliflozin, an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus. Expert Opin Drug Metab Toxicol. 


2. Osaki A et al. (2016). Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy. J Diabetes Investig.

bottom of page